abstract |
The invention provides compounds of the formula or their stereoisomers or pharmaceutically acceptable salts, where R denotes a monocyclic heteroaryl group, a R, R, R, R and R have the meaning as defined in this patent, applicable as modulators of kinases, including IRAK-4 inhibition. |